- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.70 Å
- Oligo State
- homo-dimer
- Ligands
- 4 x FES: FE2/S2 (INORGANIC) CLUSTER(Non-covalent)
- 2 x MTE: PHOSPHONIC ACIDMONO-(2-AMINO-5,6-DIMERCAPTO-4-OXO-3,7,8A,9,10,10A-HEXAHYDRO-4H-8-OXA-1,3,9,10-TETRAAZA-ANTHRACEN-7-YLMETHYL)ESTER(Non-covalent)
MTE.3: 19 residues within 4Å:- Chain A: Q.113, C.151, G.805, A.806, F.807, R.921, M.1047, G.1048, Q.1049, G.1087, G.1088, S.1089, V.1090, V.1091, A.1092, Q.1203, L.1268, E.1270
- Ligands: MOS.4
9 PLIP interactions:9 interactions with chain A- Hydrogen bonds: A:Q.113, A:A.806, A:F.807, A:M.1047, A:Q.1049, A:V.1091, A:A.1092, A:Q.1203, A:Q.1203
MTE.13: 19 residues within 4Å:- Chain B: Q.113, C.151, G.805, A.806, F.807, R.921, M.1047, G.1048, Q.1049, G.1087, G.1088, S.1089, V.1090, V.1091, A.1092, Q.1203, L.1268, E.1270
- Ligands: MOS.14
9 PLIP interactions:9 interactions with chain B- Hydrogen bonds: B:Q.113, B:A.806, B:F.807, B:M.1047, B:Q.1049, B:V.1091, B:A.1092, B:Q.1203, B:Q.1203
- 2 x MOS: DIOXOTHIOMOLYBDENUM(VI) ION(Non-covalent)
MOS.4: 9 residues within 4Å:- Chain A: Q.776, F.807, G.808, F.920, R.921, G.1087, G.1088, E.1270
- Ligands: MTE.3
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:Q.776, A:G.1088
MOS.14: 9 residues within 4Å:- Chain B: Q.776, F.807, G.808, F.920, R.921, G.1087, G.1088, E.1270
- Ligands: MTE.13
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:Q.776, B:G.1088
- 2 x FAD: FLAVIN-ADENINE DINUCLEOTIDE(Non-covalent)
FAD.5: 30 residues within 4Å:- Chain A: G.46, G.47, G.48, P.263, V.264, I.265, M.266, G.267, N.268, T.269, S.270, V.271, A.308, L.344, A.345, I.349, A.353, S.354, G.357, H.358, I.360, H.363, D.365, S.366, D.367, I.410, L.411, R.429, A.437, L.438
18 PLIP interactions:18 interactions with chain A- Hydrophobic interactions: A:A.345, A:I.349, A:I.349
- Hydrogen bonds: A:V.264, A:M.266, A:G.267, A:N.268, A:T.269, A:S.270, A:V.271, A:A.345, A:S.354, A:H.358, A:D.367, A:D.367, A:L.411, A:L.411, A:R.429
FAD.15: 30 residues within 4Å:- Chain B: G.46, G.47, G.48, P.263, V.264, I.265, M.266, G.267, N.268, T.269, S.270, V.271, A.308, L.344, A.345, I.349, A.353, S.354, G.357, H.358, I.360, H.363, D.365, S.366, D.367, I.410, L.411, R.429, A.437, L.438
20 PLIP interactions:20 interactions with chain B- Hydrophobic interactions: B:A.345, B:I.349, B:I.349
- Hydrogen bonds: B:V.264, B:M.266, B:G.267, B:N.268, B:T.269, B:T.269, B:S.270, B:V.271, B:A.345, B:S.354, B:H.358, B:D.367, B:D.367, B:D.367, B:L.411, B:L.411, B:R.429
- 2 x 4FT: phthalazine(Non-covalent)
- 2 x LZU: 10-{2-[(2S)-1-methylpiperidin-2-yl]ethyl}-2-(methylsulfanyl)-10H-phenothiazine(Non-covalent)
LZU.7: 12 residues within 4Å:- Chain A: H.575, E.577, D.578, S.1060, R.1061, R.1064, M.1065, P.1066, G.1120, W.1122, W.1125
- Ligands: RTZ.8
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:E.577, A:W.1125
LZU.17: 12 residues within 4Å:- Chain B: H.575, E.577, D.578, S.1060, R.1061, R.1064, M.1065, P.1066, G.1120, W.1122, W.1125
- Ligands: RTZ.18
2 PLIP interactions:2 interactions with chain B- Hydrophobic interactions: B:E.577, B:W.1125
- 2 x RTZ: 10-{2-[(2R)-1-methylpiperidin-2-yl]ethyl}-2-(methylsulfanyl)-10H-phenothiazine(Non-covalent)
RTZ.8: 11 residues within 4Å:- Chain A: H.575, E.577, D.578, S.1060, R.1061, R.1064, M.1065, P.1066, G.1120, W.1122
- Ligands: LZU.7
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:E.577
RTZ.18: 11 residues within 4Å:- Chain B: H.575, E.577, D.578, S.1060, R.1061, R.1064, M.1065, P.1066, G.1120, W.1122
- Ligands: LZU.17
1 PLIP interactions:1 interactions with chain B- Hydrophobic interactions: B:E.577
- 4 x MLI: MALONATE ION(Non-functional Binders)
MLI.9: 8 residues within 4Å:- Chain A: R.32, K.33, T.38, D.601, M.603, P.604, L.605, R.833
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:T.38
- Hydrogen bonds: A:R.32
- Salt bridges: A:R.32, A:K.33, A:R.833, A:R.833
MLI.10: 7 residues within 4Å:- Chain A: C.44, L.148, R.433, F.751, Y.1236, K.1237, I.1238
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:L.148
- Hydrogen bonds: A:I.1238
- Salt bridges: A:R.433, A:K.1237, A:K.1237
MLI.19: 8 residues within 4Å:- Chain B: R.32, K.33, T.38, D.601, M.603, P.604, L.605, R.833
6 PLIP interactions:6 interactions with chain B- Hydrophobic interactions: B:T.38
- Hydrogen bonds: B:R.32
- Salt bridges: B:R.32, B:K.33, B:R.833, B:R.833
MLI.20: 7 residues within 4Å:- Chain B: C.44, L.148, R.433, F.751, Y.1236, K.1237, I.1238
5 PLIP interactions:5 interactions with chain B- Hydrophobic interactions: B:L.148
- Hydrogen bonds: B:I.1238
- Salt bridges: B:R.433, B:K.1237, B:K.1237
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Coelho, C. et al., Structural Insights Into Xenobiotic and Inhibitor Binding to Human Aldehyde Oxidase. Nat.Chem.Biol. (2015)
- Release Date
- 2015-09-02
- Peptides
- ALDEHYDE OXIDASE: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.70 Å
- Oligo State
- homo-dimer
- Ligands
- 4 x FES: FE2/S2 (INORGANIC) CLUSTER(Non-covalent)
- 2 x MTE: PHOSPHONIC ACIDMONO-(2-AMINO-5,6-DIMERCAPTO-4-OXO-3,7,8A,9,10,10A-HEXAHYDRO-4H-8-OXA-1,3,9,10-TETRAAZA-ANTHRACEN-7-YLMETHYL)ESTER(Non-covalent)
- 2 x MOS: DIOXOTHIOMOLYBDENUM(VI) ION(Non-covalent)
- 2 x FAD: FLAVIN-ADENINE DINUCLEOTIDE(Non-covalent)
- 2 x 4FT: phthalazine(Non-covalent)
- 2 x LZU: 10-{2-[(2S)-1-methylpiperidin-2-yl]ethyl}-2-(methylsulfanyl)-10H-phenothiazine(Non-covalent)
- 2 x RTZ: 10-{2-[(2R)-1-methylpiperidin-2-yl]ethyl}-2-(methylsulfanyl)-10H-phenothiazine(Non-covalent)
- 4 x MLI: MALONATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Coelho, C. et al., Structural Insights Into Xenobiotic and Inhibitor Binding to Human Aldehyde Oxidase. Nat.Chem.Biol. (2015)
- Release Date
- 2015-09-02
- Peptides
- ALDEHYDE OXIDASE: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A